Italia markets close in 4 hours 49 minutes

Valneva SE (VLA.PA)

Paris - Paris Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
6,44-0,09 (-1,32%)
Al 12:21PM CET. Mercato aperto.
Schermo intero
Chiusura precedente6,53
Aperto6,50
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno6,36 - 6,54
Intervallo di 52 settimane4,95 - 29,70
Volume159.189
Media Volume427.549
Capitalizzazione900,981M
Beta (5 anni mensile)1,30
Rapporto PE (ttm)7,96
EPS (ttm)0,81
Prossima data utili10 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A11,19
  • GlobeNewswire

    Valneva Appoints Dipal Patel as Chief Commercial Officer

    Saint-Herblain (France), November 17, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dipal Patel as Chief Commercial Officer (CCO) and Management Board member. With this newly created role, Valneva strengthens its management team with a recognized commercial industry leader as the Company advances its chikungunya vaccine candidate towards potential market entry in 2023. Ms. Patel is an established commercial leader with over

  • GlobeNewswire

    Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates

    Total nine-month revenues of €249.9 million, a ~ 3.5-fold increase compared to 2021 Product sales of €74.4 million (vs €45.5 million in the first nine months of 2021) driven by a continued recovery of travel vaccine sales and by COVID-19 vaccine sales in Europe. Product sales outside of COVID-19 grew by double digits (11.2%) vs. prior period€175.5 million of other revenues (vs €24.4 million in the first nine months of 2021) mainly driven by revenue recognition related to previous COVID-19 vaccin

  • GlobeNewswire

    Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference

    Saint-Herblain (France), November 7, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its Chief Executive Officer Thomas Lingelbach and Chief Financial Officer Peter Bühler will present and participate in 1-on-1 meetings with institutional investors at the Jefferies London Healthcare Conference, to take place November 15-17, 2022 in London, England. Additionally, Mr. Lingelbach and Mr. Bühler will participate in a fireside chat on Tuesday,